On the basis of the findings reported in the present paper, we present the hypothesis that fragments and/or glycosylated isoforms of alpha-1-antitrypsin might be considered as potential biomarkers of the pathophysiological processes in the spinal cord of neuropathic pain patients. Here, SERPINA1 is linked to neuropathic pain.